Wells D - Search Results

1

Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects.

Marier JF, Beliveau M, Mouksassi MS, Shaw P, Cyran J, Kesavan J, Wallens J, Zahir H, Wells D, Caminis J. Marier JF, et al. Among authors: wells d. J Clin Pharmacol. 2008 Nov;48(11):1289-99. doi: 10.1177/0091270008320605. J Clin Pharmacol. 2008. PMID: 18974283 Clinical Trial.

2

Safety and tolerability of olopatadine 0.2% in children and adolescents.

Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Lichtenstein SJ, et al. Among authors: wells dt. J Ocul Pharmacol Ther. 2007 Aug;23(4):366-71. doi: 10.1089/jop.2007.0013. J Ocul Pharmacol Ther. 2007. PMID: 17803435 Clinical Trial.

3

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.

Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, Wells DT, Bergamini MV, Robertson SM. Abelson MB, et al. Among authors: wells dt. Clin Ther. 2004 Aug;26(8):1237-48. doi: 10.1016/s0149-2918(04)80065-1. Clin Ther. 2004. PMID: 15476905 Clinical Trial.

4

Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.

Lewis RA, Katz GJ, Weiss MJ, Landry TA, Dickerson JE, James JE, Hua SY, Sullivan EK, Montgomery DB, Wells DT, Bergamini MV; Travoprost BAC-free Study Group. Lewis RA, et al. J Glaucoma. 2007 Jan;16(1):98-103. doi: 10.1097/01.ijg.0000212274.50229.c6. J Glaucoma. 2007. PMID: 17224758 Clinical Trial.

5

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D. Topouzis F, et al. Among authors: wells ap, wells d. Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90. doi: 10.1177/112067210701700206. Eur J Ophthalmol. 2007. PMID: 17415690 Clinical Trial.

6

A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.

Denis P, Andrew R, Wells D, Friren B. Denis P, et al. Among authors: wells d. Eur J Ophthalmol. 2006 May-Jun;16(3):407-15. Eur J Ophthalmol. 2006. PMID: 16761242 Clinical Trial.

7

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM. Schuman JS, et al. Am J Ophthalmol. 2005 Aug;140(2):242-50. doi: 10.1016/j.ajo.2005.02.058. Am J Ophthalmol. 2005. PMID: 16086946 Clinical Trial.

8

The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.

Whitson JT, Ochsner KI, Moster MR, Sullivan EK, Andrew RM, Silver LH, Wells DT, James JE, Bosworth CF, Dickerson JE, Landry TA, Bergamini MV; Brimonidine 0.15% Study Group. Whitson JT, et al. Ophthalmology. 2006 Aug;113(8):1333-9. doi: 10.1016/j.ophtha.2006.03.025. Ophthalmology. 2006. PMID: 16877072 Clinical Trial.

9

Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.

Fairchild CJ, Meltzer EO, Roland PS, Wells D, Drake M, Wall GM. Fairchild CJ, et al. Among authors: wells d. Allergy Asthma Proc. 2007 Nov-Dec;28(6):716-23. doi: 10.2500/aap.2007.28.3062. Allergy Asthma Proc. 2007. PMID: 18201438

10

Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study.

Notivol R, Amin D, Whitling A, Wells D, Kennedy M, Cockrum PC; International TobraDex Study Group. Notivol R, et al. Among authors: wells d. Clin Drug Investig. 2004;24(9):523-33. doi: 10.2165/00044011-200424090-00003. Clin Drug Investig. 2004. PMID: 17523714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,454 results

Search Page